Logo

Decode s Encode, Vertex Pen Pharmacogenomics Partnership

Jan 31, 2003

NEW YORK, Jan. 31 - A Decode subsidiary will collect and analyze pharmacogenomics data for a clinical study performed by Vertex Pharmaceuticals.

 

The agreement with the unit, Encode, aims at providing Vertex with pharmacogenomics data on therapeutics responses in patients treated with Vertex drug candidate for psoriasis, the companies said.

 

The deal also may lead the partners to design pharmacogenomics tests, in which event the companies would develop and commercialize.

 

Click here for more information.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.